This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Centre for Addiction and Mental Health. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Thomas D. Prevot in Neurocognitive Health
Introduction
Thomas D. Prevot is an accomplished inventor based in Toronto, Canada. He has made significant contributions to the field of neurocognitive health through his innovative research and patents. His work focuses on addressing the challenges associated with neurocognitive decline, particularly in relation to chronic stress, aging, and neurodegenerative diseases.
Latest Patents
Thomas D. Prevot holds a patent for "Compositions and methods relating to use of agonists of ALPHA5-containing GABAA receptors." This invention provides methods and related compositions aimed at preventing neurocognitive decline. The methods are based on the use of alpha5-GABAA receptor agonists to slow or prevent harmful morphological changes in the dendrites of the hippocampus and prefrontal cortex. These changes can lead to functional decline and neurocognitive deficits.
Career Highlights
Prevot is affiliated with the Centre for Addiction and Mental Health, where he applies his expertise to advance research in mental health and neurocognitive disorders. His work is pivotal in developing therapeutic strategies that can improve cognitive function and overall mental well-being.
Collaborations
Some of his notable coworkers include Mounira Banasr and Etienne Sibille. Their collaborative efforts contribute to the ongoing research and development of innovative solutions in the field of mental health.
Conclusion
Thomas D. Prevot's contributions to neurocognitive health through his patent and research are invaluable. His work not only addresses critical issues related to cognitive decline but also paves the way for future innovations in mental health treatment.